January 8, 2026
The Minnesota Department of Human Services (DHS) has two open physician seats on its Minnesota Health Care Program’s Drug Utilization Review (DUR) Board.
The board was formed to:
monitor the prescription of covered outpatient drugs for recipients of Medicaid,
oversee prospective and retrospective interventions to target common drug therapy problems,
monitor the landscape of opioid and psychotropic medication prescribing, and
assess financial impact of interventions in the fee-for-service (FFS) Minnesota Medicaid population.
Qualified applicants must be actively practicing MDs or DOs in Minnesota with knowledge of appropriate prescribing, dispensing, and monitoring of covered outpatient drugs.
The DUR Board meets four times annually for up to two hours. There are options for in-person or virtual attendance, and Board members receive a $100 stipend per meeting attended. Term length is three years.
Applications are accepted through the Office of the Minnesota Secretary of State Boards and Commissions website, or via e-mail request to Erin Neumann, DUR coordinator. Applications received before February 6 will be considered for appointment at the March 2026 DUR Board meeting.
For more information, reach out to Erin Neumann.
April 9, 2026
An amended piece of legislation that would exempt buprenorphine from prior authorization (PA) was heard in the Senate Health and Human Services Committee on April 9.
April 9, 2026
On April 9, the Senate Health and Human Services Committee heard a bill that would require coverage for psychiatric Collaborative Care Model (CoCM) services under Medical Assistance.
April 9, 2026
On April 9, the House Taxes Committee heard legislation focused on supporting the financial stability and ongoing operations of Hennepin Healthcare.